AFP2 天
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial ...
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration ...
Don’t ignore that flutter: Irregular heartbeats could be a sign of Mitral valve disease
Mitral valve disease affects the heart's left chambers, leading to complications like atrial fibrillation and heart failure.
WebMD15 天
FDA Approves New SVT Drug for Critical Care Use
Atrial fibrillation (an irregular, rapid heartbeat) and atrial flutter (a fast, regular heartbeat) are similar but have unique risks. These conditions can last from days to years, impact heart ...
Lesser-known heart attack symptoms that aren't chest pain - and when to see a doctor
Chest pain is often considered the telltale sign of a heart attack, but there are other, lesser-known symptoms that could ...
GlobalData on MSN13 天
TCAI becomes first US medical centre to use dual-energy ablation catheter
TCAI is the first to use Medtronic’s Affera mapping and ablation system with a Sphere-9 catheter since it received FDA ...
Monthly Prescribing Reference20 天
Rapiblyk Approved to Treat Supraventricular Tachycardia
The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...